These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21116958)

  • 1. Detecting and measuring free gadolinium in nanoparticles for MRI imaging.
    Clogston JD; Patri AK
    Methods Mol Biol; 2011; 697():101-8. PubMed ID: 21116958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents.
    Moriggi L; Cannizzo C; Dumas E; Mayer CR; Ulianov A; Helm L
    J Am Chem Soc; 2009 Aug; 131(31):10828-9. PubMed ID: 19722661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging.
    Alric C; Taleb J; Le Duc G; Mandon C; Billotey C; Le Meur-Herland A; Brochard T; Vocanson F; Janier M; Perriat P; Roux S; Tillement O
    J Am Chem Soc; 2008 May; 130(18):5908-15. PubMed ID: 18407638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues.
    Arbughi T; Bertani F; Celeste R; Grotti A; Sillari S; Tirone P
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):415-26. PubMed ID: 9746258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging.
    Tseng CL; Shih IL; Stobinski L; Lin FH
    Biomaterials; 2010 Jul; 31(20):5427-35. PubMed ID: 20400176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent.
    Park JA; Kim HK; Kim JH; Jeong SW; Jung JC; Lee GH; Lee J; Chang Y; Kim TJ
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2287-91. PubMed ID: 20188545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent.
    Park JA; Reddy PA; Kim HK; Kim IS; Kim GC; Chang Y; Kim TJ
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6135-7. PubMed ID: 18938074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
    Low RN
    Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents.
    Kundu A; Peterlik H; Krssak M; Bytzek AK; Pashkunova-Martic I; Arion VB; Helbich TH; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):250-5. PubMed ID: 21194625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium toxicity: epidermis thickness measurement by magnetic resonance imaging at 500 MHz.
    Sharma R
    Skin Res Technol; 2010 Aug; 16(3):339-53. PubMed ID: 20637004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.